4//SEC Filing
Cabell Christopher 4
Accession 0000950170-25-026652
CIK 0001750149other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:10 PM ET
Size
5.4 KB
Accession
0000950170-25-026652
Insider Transaction Report
Form 4
Cabell Christopher
President & Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2025-02-21+1,100,705→ 1,100,705 totalExercise: $2.23Exp: 2035-02-21→ Common Stock (1,100,705 underlying)
Footnotes (1)
- [F1]The options will vest in three substantially equal installments on the second, third and fourth anniversaries of February 21, 2025, subject to the Reporting Person's continued services through such date.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001814928
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 4:10 PM ET
- Size
- 5.4 KB